Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4

Rhea-AI Filing Summary

Ampofo William A. II reported acquisition or exercise transactions in this Form 4 filing.

Baxter International Inc. director William A. Ampofo II received a stock grant of 12,836 shares of common stock. The shares were granted at no cash cost to him as a fully vested award, increasing his directly held stake to 30,375 shares, including shares from automatic dividend reinvestment.

This Form 4 reflects a compensation-related grant, not an open-market purchase or sale, and does not indicate any change in his trading views on Baxter stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ampofo William A. II

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $1 par value	12,836	$0.00	--

Holdings After Transaction: Common Stock, $1 par value — 30,375 shares (Direct, null)

Footnotes (1)

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends.

Key Figures

Stock grant size: 12,836 shares Grant price: $0.00 per share Shares after transaction: 30,375 shares

3 metrics

Stock grant size 12,836 shares Fully vested common stock grant on 2026-05-05

Grant price $0.00 per share Reported transaction price for the award

Shares after transaction 30,375 shares Total Baxter common stock directly held after grant

Key Terms

fully vested shares, automatic reinvestment of dividends, grant, award, or other acquisition

3 terms

fully vested shares financial

"received a grant of fully vested shares of common stock of Baxter International Inc."

automatic reinvestment of dividends financial

"Total includes the automatic reinvestment of dividends."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ampofo William A. II

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $1 par value	05/05/2026		A		12,836(1)	A	$0	30,375(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

2. Total includes the automatic reinvestment of dividends.

Remarks:

	/s/ Kimberly Olson, as attorney in-fact for William A. Ampofo, II	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Baxter (BAX) director William A. Ampofo II report in this Form 4?

He reported receiving a grant of 12,836 fully vested shares of Baxter common stock. This award was issued at no cash cost to him and is compensation-related, not an open-market trade, so it mainly updates his ownership position rather than signaling a trading decision.

How many Baxter (BAX) shares does William A. Ampofo II hold after this grant?

After the grant, he directly holds 30,375 Baxter common shares. This total reflects both the newly granted 12,836 fully vested shares and prior holdings, which include shares accumulated through the automatic reinvestment of dividends under Baxter’s relevant programs.

Was the Baxter (BAX) Form 4 transaction a stock purchase or sale?

The filing shows no open-market purchase or sale. Instead, it records a compensation-related grant coded as an acquisition, with 12,836 fully vested shares awarded at a reported price of $0.00 per share, meaning no cash changed hands in this transaction.

What does “fully vested shares” mean in this Baxter (BAX) Form 4 filing?

Fully vested shares are immediately owned without additional time-based vesting conditions. In this case, the director’s 12,836-share grant is fully vested upon award, subject only to the terms and conditions of Baxter’s applicable grant agreement, as noted in the filing’s footnote.

Does the Baxter (BAX) Form 4 mention dividend reinvestment for the director’s holdings?

Yes. A footnote explains the reported total includes shares from automatic reinvestment of dividends. This means some of the 30,375 shares reflect dividends paid on existing holdings that were automatically used to acquire additional Baxter common stock over time.